FDA establishment 3011040559, India. Part of Cipla's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FDA has posted no inspections for this site.
| Product | Charges | Latest |
|---|---|---|
| OXCARBAZEPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II)Drugs · 66NDA07 | Oct 23, 2026 | |
| IPRATROPIUM BROMIDE (BRONCHODILATOR)Drugs · 63BDQ26 | Oct 22, 2024 | |
| CARVEDILOL (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCY22 | Oct 8, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters
India. Part of